NEW YORK (GenomeWeb News) — Seattle-based firm LabKey Software, a maker of open-source software for researchers working on large-scale, collaborative projects, said today that it has joined the BioIT Alliance.
 
The Microsoft-led BioIT Alliance is a consortium of software and biotechnology companies that are working together to advance personalized medicine and drug development using the Microsoft platform.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.